NHS to trial Group B Strep infection screening in pregnant women in a bid to protect newborns The NHS will conduct a major trial into Group B Strep screening in pregnant women in a bid to protect newborns from deadly illnesses.
The £2.8million study will compare what is considered the 'gold standard' ECM test, as well as the 'bedside test', with current standards of care.
If rolled out in NHS hospitals, the tests could prevent Group B Strep (GBS) infection in around 350 babies every year. The Daily Mail
No comments:
Post a Comment